The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Ido Wolf

The Institute of Oncology

Chaim Sheba Medical Center

Ramat Gan

Israel

[email]@inter.net.il

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • The Institute of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel. 2006 - 2010
  • Division of Hematology/Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, USA. 2006 - 2007
  • Department of Internal Medicine E, Sheba Medical Center, Tel Hashomer, Israel. 2002 - 2006

References

  1. Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin. Wolf, I., Laitman, Y., Rubinek, T., Abramovitz, L., Novikov, I., Beeri, R., Kuro-O, M., Koeffler, H.P., Catane, R., Freedman, L.S., Levy-Lahad, E., Karlan, B.Y., Friedman, E., Kaufman, B. Oncogene (2010) [Pubmed]
  2. Association between standard clinical and pathologic characteristics and the 21-gene recurrence score in breast cancer patients: a population-based study. Wolf, I., Ben-Baruch, N., Shapira-Frommer, R., Rizel, S., Goldberg, H., Yaal-Hahoshen, N., Klein, B., Geffen, D.B., Kaufman, B. Cancer (2008) [Pubmed]
  3. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Wolf, I., Levanon-Cohen, S., Bose, S., Ligumsky, H., Sredni, B., Kanety, H., Kuro-o, M., Karlan, B., Kaufman, B., Koeffler, H.P., Rubinek, T. Oncogene (2008) [Pubmed]
  4. Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer. Wolf, I., Bose, S., Desmond, J.C., Lin, B.T., Williamson, E.A., Karlan, B.Y., Koeffler, H.P. Breast Cancer Res. Treat. (2007) [Pubmed]
  5. Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest. Wolf, I., O'Kelly, J., Wakimoto, N., Nguyen, A., Amblard, F., Karlan, B.Y., Arbiser, J.L., Koeffler, H.P. Int. J. Oncol. (2007) [Pubmed]
  6. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Wolf, I., Sadetzki, S., Kanety, H., Kundel, Y., Pariente, C., Epstein, N., Oberman, B., Catane, R., Kaufman, B., Shimon, I. Cancer (2006) [Pubmed]
  7. Association between diabetes mellitus and adverse characteristics of breast cancer at presentation. Wolf, I., Sadetzki, S., Gluck, I., Oberman, B., Ben-David, M., Papa, M.Z., Catane, R., Kaufman, B. Eur. J. Cancer (2006) [Pubmed]
  8. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. Wolf, I., O'Kelly, J., Rubinek, T., Tong, M., Nguyen, A., Lin, B.T., Tai, H.H., Karlan, B.Y., Koeffler, H.P. Cancer Res. (2006) [Pubmed]
  9. The mitogen-activated protein kinase signaling cascade: from bench to bedside. Wolf, I., Seger, R. Isr. Med. Assoc. J. (2002) [Pubmed]
 
WikiGenes - Universities